Free Trial

NeuroSense Therapeutics (NRSNW) Competitors

$0.78 -0.03 (-3.70%)
As of 10:44 AM Eastern

NRSNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying NeuroSense Therapeutics stock or one of its competitors? The main competitors of NeuroSense Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

NeuroSense Therapeutics vs. Its Competitors

NeuroSense Therapeutics (NASDAQ:NRSNW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

In the previous week, NeuroSense Therapeutics' average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that NeuroSense Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
NeuroSense Therapeutics Very Positive
180 Life Sciences Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroSense TherapeuticsN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
NeuroSense TherapeuticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Summary

NeuroSense Therapeutics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get NeuroSense Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRSNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRSNW vs. The Competition

MetricNeuroSense TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$129.53M$5.54B$9.41B
Dividend YieldN/A3.74%3.75%4.03%
P/E RatioN/A3.5928.0119.82
Price / SalesN/A4,198.65433.8198.96
Price / CashN/A13.1936.1658.27
Price / BookN/A37.888.125.65
Net IncomeN/A-$90.99M$3.25B$257.91M
7 Day Performance41.82%0.87%0.97%2.09%
1 Month Performance-2.50%5.80%7.36%11.13%
1 Year Performance191.79%162.54%31.31%18.40%

NeuroSense Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRSNW
NeuroSense Therapeutics
N/A$0.78
-3.7%
N/A+203.0%$0.00N/A0.0010Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
+18.7%
N/A-24.6%$0.00N/A0.007Positive News
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.18
+5.9%
N/AN/A$0.00$106.21K0.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$1.54
-14.4%
N/A-38.2%$0.00$585.60M0.004Positive News
Gap Up
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+75.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
+2.9%
N/AN/A$0.00$38.00M0.0070Positive News
BTMDW
biote
N/A$0.01
+16.1%
N/A-97.3%$0.00$199.38M0.00N/AGap Up
BCTXW
BriaCell Therapeutics
N/A$0.04
-4.6%
N/A-73.9%$0.00N/A0.008

Related Companies and Tools


This page (NASDAQ:NRSNW) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners